Shalby Ltd's Q3FY25 Quarter Results
- 04 Feb 2025
Result Summary
- Shalby Ltd reported a 2.3% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 27.4%.
- Its expenses for the quarter were up by 3.0% QoQ and 41.6% YoY.
- The net profit decreased 226.7% QoQ and decreased 115.7% YoY.
- The earnings per share (EPS) of Shalby Ltd declined at 0.3 during Q3FY25.
Financial Statments for Q3FY25
| (₹ crores) | Q3FY25 | Q2FY25 | Q3FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 281.05 | 274.70 | 220.57 | 2.3% | 27.4% |
Total Expenses | 268.71 | 260.99 | 189.75 | 3.0% | 41.6% |
Profit Before Tax | 12.35 | 13.70 | 30.81 | -9.9% | -59.9% |
Tax | 15.34 | 11.34 | 11.75 | 35.3% | 30.6% |
Profit After Tax | -2.99 | 2.36 | 19.06 | -226.7% | -115.7% |
Earnings Per Share | -0.30 | 0.20 | 1.80 | -250.0% | -116.7% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Shalby Ltd is a prominent player in the healthcare industry, primarily engaged in providing healthcare services. The company operates a chain of multi-specialty hospitals offering a wide range of medical services, including orthopedics, cardiology, oncology, and more. Shalby Ltd has established itself as a trusted name in healthcare with its focus on quality service and patient care. Recent developments for the company could include expansions, new facility openings, or strategic partnerships, though specific details are not available in the given data. Understanding the company's business model and industry context is crucial for analyzing its financial performance.
Revenue
For the third quarter of fiscal year 2025 (Q3FY25), Shalby Ltd reported a total income of ₹281.05 crores. This marks a quarter-over-quarter (QoQ) increase of 2.3% from ₹274.70 crores in Q2FY25, and a year-over-year (YoY) increase of 27.4% from ₹220.57 crores in Q3FY24. These figures indicate a positive trajectory in revenue growth over the specified periods. The consistent increase in total income reflects the company's ability to enhance its revenue streams, possibly through an increase in patient volumes or service offerings. The rise in revenue compared to the previous year is significant, suggesting an expansion in operations or increased market share.
Profitability
The profitability metrics for Shalby Ltd present a mixed picture for the reported quarter. The profit before tax (PBT) for Q3FY25 was ₹12.35 crores, a decrease of 9.9% QoQ from ₹13.70 crores in Q2FY25, and a substantial decline of 59.9% YoY from ₹30.81 crores in Q3FY24. The tax component increased by 35.3% QoQ and 30.6% YoY, leading to a negative profit after tax (PAT) of -₹2.99 crores for Q3FY25, down from a positive PAT of ₹2.36 crores in Q2FY25 and ₹19.06 crores in Q3FY24. This resulted in a negative earnings per share (EPS) of -₹0.30 for Q3FY25, compared to ₹0.20 in Q2FY25 and ₹1.80 in Q3FY24. The declining profitability indicators, despite rising revenues, suggest increased costs or operational challenges impacting the bottom line.
Operating Metrics
Shalby Ltd's total expenses for Q3FY25 amounted to ₹268.71 crores, representing a QoQ increase of 3.0% from ₹260.99 crores in Q2FY25, and a YoY rise of 41.6% from ₹189.75 crores in Q3FY24. The company's expense growth outpaced its revenue growth on both a QoQ and YoY basis, which may have contributed to the decline in profitability. The higher expenses could be attributed to increased operational costs, investments in infrastructure, or expansions. Understanding these expenses in relation to total income provides insight into the company’s operational efficiency and cost management strategies during the reported period.
